FTWA
ABBV icon

Fifth Third Wealth Advisors’s AbbVie ABBV Stock Holding History

Fifth Third Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Buy
51,073
+1,585
+3% +$341K 0.36% 49
2026
Q1 		$10.8M Buy
49,488
+2,077
+4% +$461K 0.36% 48
2025
Q4 		$10.8M Sell
47,411
-94
-0.2% -$21.4K 0.38% 42
2025
Q3 		$11M Buy
47,505
+889
+2% +$181K 0.41% 41
2025
Q2 		$8.65M Sell
46,616
-4,542
-9% -$844K 0.36% 44
2025
Q1 		$10.7M Buy
51,158
+7,387
+17% +$1.44M 0.56% 30
2024
Q4 		$7.78M Sell
43,771
-361
-0.8% -$66.4K 0.42% 36
2024
Q3 		$8.72M Buy
44,132
+5,640
+15% +$1.05M 0.53% 27
2024
Q2 		$6.6M Buy
38,492
+7,349
+24% +$1.22M 0.5% 29
2024
Q1 		$5.67M Buy
31,143
+6,509
+26% +$1.12M 0.88% 18
2023
Q4 		$3.82M Buy
24,634
+1,627
+7% +$237K 1.24% 15
2023
Q3 		$3.43M Buy
23,007
+6,491
+39% +$953K 1.38% 12
2023
Q2 		$2.23M Buy
16,516
+10,487
+174% +$1.54M 1.43% 15
2023
Q1 		$961K Buy
+6,029
New +$922K 1.78% 16

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Fifth Third Wealth Advisors's ABBV Position: Q2 2026 in Review

Fifth Third Wealth Advisors increased its AbbVie (ABBV) stake by 3.2% in Q2 2026, buying an estimated $341K and bringing the position to 51,073 shares worth $12.9M. The position accounts for 0.36% of the portfolio, ranked #49.

Fifth Third Wealth Advisors first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fifth Third Wealth Advisors held 51,073 shares of AbbVie worth $12.9M as of Q2 2026.
  • Fifth Third Wealth Advisors bought 1,585 AbbVie shares in Q2 2026, an estimated $341K.
  • AbbVie made up 0.36% of Fifth Third Wealth Advisors's portfolio in Q2 2026, its #49 holding.
  • Fifth Third Wealth Advisors first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.